This Web site is administered by Genetics Policy Institute (GPI). All rights and title in and to www.genpol.org reside with GPI.
Your access to and use of this site is subject to the following terms and conditions and all applicable laws. By accessing and using this site, you accept the following terms and conditions without limitation or qualification.
Unless otherwise stated, the contents of this site including, but not limited to, the text and images contained herein and their arrangement are the property of GPI or, in the case of materials sourced from third parties, the owner of the original source material. All images of artwork, work product or trademarks used or referred to in this Web site are the property of their respective owners.
GPI has attempted on a best-efforts basis to properly cite, acknowledge and/or reference copyrighted or otherwise protected third-party content. You understand and agree that any failure on GPI's part to properly acknowledge any third-party source is inadvertent and that you will not take or initiate legal action against GPI, either directly or indirectly through correspondence with others. In the event that you identify content on this Web site that is improperly used or sourced, you are free to contact GPI and request that GPI either remove or correct this content. GPI will, in turn, make necessary changes on a best-efforts basis.
Nothing contained in this site shall be construed as conferring by implication, estoppel or otherwise, any license or right to any copyright, patent, trademark or other proprietary interest of GPI or any third-party. This site and the content provided in this site, may not be copied, reproduced, republished, uploaded, posted, transmitted or distributed in any way without the prior written consent of GPI.
The information provided on this site is free of charge and for informational purposes only and does not create a business or professional services relationship between you and GPI. Links on this site may lead to services or sites not owned or operated by GPI. No judgment or warranty is made with respect to such other services or sites and GPI takes no responsibility for such other sites or services. A link to another site or service is not an endorsement of that site or service. Any use you make of the information provided on this site, or any site or service linked to by this site, is at your own risk.
If you have any questions now or during your visit, please contact us.
- San Antonio could see significant gains from World Stem Cell Summit
December 11, 2014
- WSCS14 Poster Forum Winners Announced
December 5, 2014
- Conquer Paralysis Now Launches Challenge to Find a Cure in Next Decade
December 5, 2014
Genetics Policy Institute (GPI) and the Regenerative Medicine Foundation (RMF) Announce Merger Plan
The Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and the Regenerative Medicine Foundation (RMF) have agreed to merge in order to leverage their resources in the advancement of stem cell research, regenerative medicine and other advanced technologies targeting cures.
Bernard Siegel's TedX talk "Stem Cells and the Transformative Power of Hope"
Bernard Siegel, a leader of the global stem cell advocacy movement and founder of the World Stem Cell Summit, describes how grassroots activists have contributed to the advancement of stem cell research, one of the greatest scientific breakthroughs of our time.
World Stem Cell Summit 2014
The 2014 World Stem Cell Summit took place in San Antonio, Texas on December 3-5, 2014 at the Marriott Rivercenter. The Summit featured a record 200 expert speakers leading 67 sessions and panels and 37 "Conversation with Experts" roundtable discussions. Twelve hundred WSCS14 attendees represented more than 40 countries.
- BEINGS 2015
- World Stem Cell Summit
- RegMed Capital Conference